|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bacterial Vaginosis | |||||
| Candidiasis | |||||
| Vaginitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Vaginal Discharge | |||||
| Vaginosis, Bacterial | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Genital Diseases, Female | |||||
| Mycoses | |||||
| Vaginal Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Clotrimazole | |||||
| Fluconazole | |||||
| Metronidazole | |||||
| Miconazole | |||||
| Tinidazole | |||||
| Tioconazole | |||||
| 5 | More general drug interventions related to this trial | ||||
| Alkylating Agents | |||||
| Anti-Infective Agents | |||||
| Anti-Infective Agents, Local | |||||
| Antifungal Agents | |||||
| Antiparasitic Agents | |||||
| Antiprotozoal Agents | |||||
| Antitrichomonal Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Universitaire de Sherbrooke | |||||
| Canadian International Development Agency | |||||